Work

Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR‐TIMI 53 cardiovascular outcomes trials

Year: 2021

Type: article

Source: Diabetes Obesity and Metabolism

DOI: 10.1111/dom.14313

Authors: Lindsay E. Clegg, Yankang Jing, Robert C. Penland, David W. Boulton, Adrian F. Hernandez, Rury R. Holman, Jiten Vora

Institutions: AstraZeneca (United States), University of Pittsburgh, Duke University, Duke Medical Center, University of Oxford, University of Liverpool

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, National Institute for Health and Care Research

Award: NIHR Senior Investigator Award

OpenAlex ID: W3118272952

FWCI: 0.941

Cites: 35

Cited by: 9

Related to: 10